Position in TCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$175,378
-$50,451 QoQ
Shares Held
173,643
-23.1% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. TCRX ranks #335 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in TCRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $175,378 | 173,643 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $225,829 | 225,829 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,542,515 | 847,537 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,237,350 | 853,346 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $818,297 | 592,970 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,255,087 | 412,858 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,490,605 | 299,319 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,413,780 | 241,672 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,777,716 | 223,894 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,368,318 | 234,703 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $664,184 | 259,447 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $271,187 | 108,475 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $275,769 | 131,319 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $65,371 | 42,175 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $196,938 | 64,570 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $179,544 | 57,089 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $109,412 | 39,076 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $123,317 | 27,404 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $235,488 | 28,236 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||